Valneva(US:VALN)2025-11-20 11:04Financial Performance - Revenues for the nine months ended September 30, 2025, increased to €126,971 thousand, up 8.4% from €116,637 thousand in 2024[1] - Product sales rose to €119,397 thousand, a 6.9% increase compared to €112,475 thousand in the same period last year[1] - Operating loss for the period was €53,945 thousand, compared to an operating profit of €34,214 thousand in 2024[1] - Net loss for the period was €65,173 thousand, a significant decline from a profit of €24,740 thousand in the previous year[2] - Total comprehensive loss for the period amounted to €64,429 thousand, compared to a comprehensive income of €25,342 thousand in 2024[2] Cash and Assets - Cash and cash equivalents decreased to €143,462 thousand from €168,271 thousand at the beginning of the year[5] - Non-current assets decreased to €179,900 thousand from €201,020 thousand as of December 31, 2024[4] - Total equity as of September 30, 2025, was €150,477 thousand, down from €181,253 thousand at the end of 2024[4] - Current liabilities increased to €150,481 thousand from €114,580 thousand at the end of 2024[4] Research and Development - Research and development expenses rose to €59,729 thousand, up 23.0% from €48,567 thousand in the same period last year[1]